Breast cancer susceptibility gene

November 30, 2000

Breast cancer is the most common cancer among women, and the second leading cause of mortality from cancer. The American Cancer Society estimates that in the US this year, over 182,000 women have been newly diagnosed with invasive breast cancer. Mutations in the so-called breast cancer susceptibility gene, BRCA1, account for 40-50% of early onset familial breast cancer cases and >75% of familial breast/ovarian cancer cases. Recently, scientists have discovered that the protein ATR is responsible for activating BRCA1 in response to UV light-induced DNA damage. As published in Genes & Development, this discovery provides the first evidence that ATR may be the newest breast cancer susceptibility gene.

Our genomes are under frequent attack by environmental carcinogens, metabolic byproducts and spontaneous mutations. On a daily basis we are exposed to UV light, which can introduce covalent bonds between adjacent bases in DNA, thereby altering the normal double-helical shape of DNA and blocking its replication. Whether or not this DNA damage is repaired properly is a primary determinant in the development of cancer. DNA damage repair involves a cascade of phosphorylating enzymes, or kinases, which regulate the action of specific repair proteins. BRCA1 is believed to be one of these repair proteins. In cells that have lost BRCA1 function, there are increased rates of mutation in response to DNA damage, and therefore a greater susceptibility to cancer.

Dr. Abraham and colleagues have discovered that after cells are exposed to UV light, the kinase ATR phosphorylates BRCA1 at six different sites. By up-regulating or down-regulating ATR expression levels, Dr. Abraham and colleagues were able to observe that BRCA1 phosphorylation increases or decreases, respectively. Phosphorylated BRCA1 relocalizes to distinct sites of DNA damage within the cell nucleus, and presumably aids in their repair. In addition to more clearly delineating the pathway of BRCA1 response to UV light-induced DNA damage, Dr. Abraham and colleagues have found that mutations which alter ATR expression or activity may increase one's susceptibility to the development of breast cancer.

Cold Spring Harbor Laboratory

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to